Oral Pill for Sleep Apnea Shows Promising Results In Trial

Oral Pill for Sleep Apnea Shows Promising Results In Trial In the most recent trial carried out on the drug AD109, over 40% of participants’ conditions improved to a less severe obstructive sleep apnea classification, 18% achieved complete control of the disease, and breathing interruptions fell by 44% in patients who took the medication, The Hill reported. The FDA has given AD109 the Fast Track designation. https://kffhealthnews.org/morning-breakout/pharma-and-tech-091826/